Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M van Laar

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Arthritis Research|November 30, 2000
Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantationJ M van Laar
Rheumatology (Oxford, England)|June 17, 2006
Adult stem cells in the treatment of autoimmune diseasesJ M van Laar, A Tyndall
Genes and Immunity|July 18, 2014
Emerging role of epigenetics in systemic sclerosis pathogenesisM Ciechomska, J M van Laar, S O'Reilly
Annals of the Rheumatic Diseases|September 16, 2005
Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosisJ M van Laar, D Farge, A Tyndall
Annals of the Rheumatic Diseases|December 17, 2008
Stem cell transplantation: a treatment option for severe systemic sclerosis?J M van Laar, D Farge, A Tyndall
Rheumatology (Oxford, England)|July 11, 2000
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?J M van Laar, R J Verburg, J K Sont
Rheumatology (Oxford, England)|January 2, 2003
Superior effect of arthroscopic lavage compared with needle aspiration in the treatment of inflammatory arthritis of the kneeM van Oosterhout, J K Sont, J M van Laar
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in rheumatoid arthritis: Focus on rituximabY K Teng, T W Huizinga, J M van Laar
Journal of Scleroderma and Related Disorders|April 7, 2022
Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literatureAnkoor Shah, J Spierings, J M van Laar, et al.
Clinical and Experimental Immunology|January 29, 2020
The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantationN H Servaas, J Spierings, A Pandit, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Arthritis Research|November 30, 2000
Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantationJ M van Laar
Rheumatology (Oxford, England)|June 17, 2006
Adult stem cells in the treatment of autoimmune diseasesJ M van Laar, A Tyndall
Genes and Immunity|July 18, 2014
Emerging role of epigenetics in systemic sclerosis pathogenesisM Ciechomska, J M van Laar, S O'Reilly
Annals of the Rheumatic Diseases|September 16, 2005
Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosisJ M van Laar, D Farge, A Tyndall
Annals of the Rheumatic Diseases|December 17, 2008
Stem cell transplantation: a treatment option for severe systemic sclerosis?J M van Laar, D Farge, A Tyndall
Rheumatology (Oxford, England)|July 11, 2000
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?J M van Laar, R J Verburg, J K Sont
Rheumatology (Oxford, England)|January 2, 2003
Superior effect of arthroscopic lavage compared with needle aspiration in the treatment of inflammatory arthritis of the kneeM van Oosterhout, J K Sont, J M van Laar
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in rheumatoid arthritis: Focus on rituximabY K Teng, T W Huizinga, J M van Laar
Journal of Scleroderma and Related Disorders|April 7, 2022
Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literatureAnkoor Shah, J Spierings, J M van Laar, et al.
Clinical and Experimental Immunology|January 29, 2020
The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantationN H Servaas, J Spierings, A Pandit, et al.
Pageof 10